Latest filing published 12 Jan 2023 for Edesa Biotech, Inc., €23k.
Filing timeline
BuySaleInsider track record
Lumira Capital Investment Management Inc.: trading record in brief
This profile gathers the share dealings of Lumira Capital Investment Management Inc. in Edesa Biotech, Inc. Between 2 November 2020 and 10 January 2023, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 4 sales worth €549k. Outside the open market, there are 2 option exercises. 2023 to date brings no purchases and 4 sales.
On 12 January 2023 came the latest disclosure, an open-market sale for €23k in Edesa Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lumira Capital Investment Management Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,284 shares@ CA$2.66214.2% of flowCommon SharesTSXSEDI:4062207
- 132,845 shares@ CA$2.662145.0% of flowCommon SharesTSXSEDI:4062206
- 12,895 shares@ CA$2.63464.3% of flowCommon SharesTSXSEDI:4062209
- 139,450 shares@ CA$2.634646.5% of flowCommon SharesTSXSEDI:4062208
- 64,362 shares@ CA$4.00Common SharesTSXSEDI:3623003
- 5,952 shares@ CA$4.00Common SharesTSXSEDI:3623007
6 of 6 declarations
